Sky Century Investment (SKYI) Times Interest Earned (2024 - 2025)
Sky Century Investment (SKYI) posted quarterly Times Interest Earned of -$60.28 for Q3 2025, down 85946.56% quarter-over-quarter from -$0.07 in Q2 2025.
Sky Century Investment (SKYI) Times Interest Earned (2024 - 2025) Analysis & Trends
Sky Century Investment (SKYI) has reported Times Interest Earned for 2 consecutive years, with -$60.28 the latest figure, recorded in Q3 2025.
- In Q3 2025, Times Interest Earned changed N/A year-over-year to -$60.28; the TTM figure through May 2026 stood at -$105.14 (down 23368.94% YoY), while the FY2025 annual figure was -$0.6, down 39.62% from the prior year.
- Times Interest Earned eased to -$60.28 in Q3 2025 per SKYI's latest filing, from -$0.07 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.07 in Q2 2025 and bottomed at -$80.15 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2025 | -60.28 |
| May 31, 2025 | -0.07 |
| Feb 28, 2025 | -0.15 |
| Nov 30, 2024 | -80.15 |